Folic acid metabolism and malaria

Food and Nutrition Bulletin

Volumn 28, Issue 4 SUPPL., 2007, Pages

  Metz, Jack ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Children; Folate; Malaria; Supplementation

Indexed keywords

ANEMIA; CHILD HEALTH; CONFERENCE PROCEEDING; DISEASE PREVALENCE; FOOD SUPPLEMENTATION; HEALTH RISK; MALARIA; METABOLISM; NUTRITIVE VALUE; VITAMIN DEFICIENCY; WORLD HEALTH ORGANIZATION;

PLASMODIUM FALCIPARUM;

EID: 38549128269     PISSN: 03795721     EISSN: None     Source Type: Journal    
DOI: 10.1177/15648265070284s407     Document Type: Conference Paper

References (77)

1. WHO Expert Committee on Malaria. World Health Organ Tech Rep Ser 2000;892:i-v,1-74.
2. Baird JK. Effectiveness of antimalarial drugs. N Engl J Med 2005;352:1565-77.
3. Chanarin I. The megaloblastic anemias, 2nd ed. Oxford, UK: Blackwell Scientific, 1979.
4. Hyde JE. Exploring the folate pathway in Plasmodium falciparum. Acta Trop 2005;94:191-206.
5. Wang P, Wang Q, Aspinall TV, Sims PF, Hyde JE. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum. Mol Microbiol 2004;51:1425-38.
6. Krungkrai J, Webster HK, Yuthavong Y. De novo and salvage biosynthesis of pteroylpentaglutarnates in the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol 1989;32:25-37.
7. Watkins WM, Sixsmith DG, Chulay JD, Spencer HC. Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. Mol Biochem Parasitol 1985;14:55-61.
8. Milhous WK, Weatherly NF, Bowdre JH, Desjardins RE. In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrob Agents Chem-other 1985;27:525-30.
9. Wang P, Read M, Sims PF, Hyde JE. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol Microbiol 1997;23:979-86.
10. Wang P, Brobey RK, Horii T, Sims PF, Hyde JE. Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy. Mol Microbiol 1999;32:1254-62.
11. Ferone R. Folate metabolism in malaria. Bull World Health Organ 1977;55:291-8.
12. Peters W. Chemotherapy and drug resistance in malaria. 2nd ed. London: Academic Press, 1987.
13. Das KC, Virdi JS, Herbert V. Survival of the dietarily deprived: folate deficiency protects against malaria in primates. Blood 1992;80(suppl 1):281a.
14. Hamilton PJ, Gebbie DA, Wilks NE, Lothe F. The role of malaria, folic acid deficiency and haemoglobin AS in pregnancy at Mulago hospital. Trans R Soc Trop Med Hyg 1972;66:594-602.
15. Hercberg S, Chauliac M, Galan P, Devanlay M, Zohoun I, Agboton Y, Soustre Y, Bories C, Christides JP, Potier de Courcy G, Masse-Raimbault A-M, Dupin H. Relationship between anaemia, iron and folacin deficiency, haemoglobinopathies and parasitic infection. Hum Nutr Clin Nutr 1986;40:371-9.
16. Brabin BJ. A comparison of maternal and foetal folacin and cobalamin activities at parturition in relation to Plasmodium falciparum infection. Trans R Soc Trop Med Hyg 1985;79:652-6.
17. Bradley-Moore AM, Greenwood BM, Bradley AK, Akintunde A, Attai ED, Fleming AF, Flynn FV, Kirkwood BR, Gilles HM. Malaria chemoprophylaxis with chloroquine in young Nigerian children. IV. Its effect on haematological measurements. Ann Trop Med Parasitol 1985;79:585-95.
18. Abdalla SH. Iron and folate status in Gambian children with malaria. Ann Trop Paediatr 1990;10:265-72.
19. van Hensbroek MB, Morris-Jones S, Meisner S, Jaffar S, Bayo L, Dackour R, Phillips C, Greenwood BM. Iron, but not folic acid, combined with effective antimalarial. therapy promotes haematological recovery in African children after acute falciparum. malaria. Trans R Soc Trop Med Hyg 1995;89:672-6.
20. Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, Plowe CV, Smith PJ. Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 2005;72:267-72.
21. Mulenga M, Malunga P, Bennett S, Thuma P, Shulman C, Fielding K, Greenwood B. Folic acid treatment of Zambian children with moderate to severe malaria anemia. Am J Trop Med Hyg 2006;74:986-90.
22. Oppenheimer SJ, Cashin P. Serum and red cell folate levels associated with malarial parasitaemia. Trans R Soc Trop Med Hyg 1986;80:169-71.
23. Trager W, The enhanced folic and folinic acid contents of erythrocytes infected with malaria parasites. Exp Parasitol 1959;8:265-73.
24. Reid VE, Friedkin M. Plasmodium berghei: Folic acid levels in mouse erythrocytes. Exp Parasitol 1973;33:424-8.
25. Brabin BJ, van den Berg H, Nijmeyer F. Folacin, cobalamin, and hematological status during pregnancy in rural Kenya: The influence of parity, gestation, and Plasmodium falciparum malaria. Am J Clin Nutr 1986; 43:803-15.
26. Fleming AF, Hendrickse JP, Allan NC. The prevention of megaloblastic anaemia in pregnancy in Nigeria. J Obstet Gynaecol Br Commonw 1968;75:425-32.
27. Fleming AF. Haematological manifestations of malaria and other parasitic diseases. Clin Haematol 1981;10:983-1011.
28. Strickland GT, Kostinas JE. Folic acid deficiency complicating malaria. Am J Trop Med Hyg 1970;19:910-5.
29. Bukirwa H, Garner P. Critchley J. Chlorproguanildapsone for treating uncomplicated malaria. Cochrane Database Syst Rev 2004;18:CD004387.
30. Ferone R, Burchall JJ, Hitchings GH. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates. Mol Pharmacol 1969;5:49-59.
31. Platzer EG. Dibydrogolate reductase in Plasmodium lophurae and duckling erythrocytes. J Protozool 1974;21:400-5.
32. Rollo IM. Antiplasmodial efficacy of 2,4-diaminopyrimidine-sulfonamide combinations, especially against chloroquine-resistant malaria. Can Med Assoc J 1975;112(13 spec no):50-3.
33. Chulay JD, Watkins WM, Sixsmith DG. Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. Am J Trop Med Hyg 1984;33:325-30.
34. Hurly MG. Potentiation of pyrimethamine by sulphadiazine in human malaria. Trans R Soc Trop Med Hyg 1959; 53:412-3.
35. Waxman S, Herbert V. Mechanism of pyrimethamine-induced megaloblastosis in human bone marrow. N Engl J Med 1969;280:1316-9.
36. Myatt AV, Hernandez T, Coatney GR. Studies in human malaria. XXXIII. The toxicity of pyrimethamine (daraprim) in man. Am J Trop Med Hyg 1953;2:788-94.
37. Hughes A, Gatus BJ. Severe megaloblastic anaemia caused by maloprim. J Trop Med Hyg 1979;82:120-1.
38. Stürchler D, Holzer B. Low serum folate among persons taking Fansidar (pyrimethamine plus sulfadoxine) for prophylaxis of malaria. Acta Trop 1980;37:243-8.
39. Fuller NJ, Bates CJ, Hayes RJ, Bradley AK, Greenwood AM, Talloch S, Greenwood BM. The effects of antimalarials and folate supplements on haematological indices and red cell folate levels in Gambian children. Ann Trop Paediatr 1988;8:61-7.
40. Peterson DS, Walliker D, Wellems TE. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum. malaria. Proc Natl Acad Sci USA 1988;85:9114-8.
41. Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: What next? Trends Parasitol 2001;17:582-8.
42. Nzila AM, Mberu EK, Sulo J, Dayo H, Winstanley PA, Sibley CH, Watkins WM. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: Genotyping of dihydrofolate reductase and dibydropteroate synthase of Kenyan parasites. Antimicrob Agents Chemother 2000;44:991-6.
43. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 2002;185:380-8.
44. Staedke SG, Sendagire H, Lamola S, Kamya MR, Dorsey G, Rosenthal PJ. Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda. Trop Med Int Health 2004;9:624-9
45. Thompson PE, Werbel LM. Antimalarial agents: chemistry and pharmacology. New York: Academic Press, 1972.
46. Kinyanjui SM, Mberu EK, Winstanley PA, Jacobus DP. Watkins WM. The antimalarial triazine WR99210 and the prodrug PS-15: Folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug. Am J Trop Med Hyg 1999;60:943-7.
47. Carter JY, Loolpapit MP, Lema OE, Tome JL, Nagelkerke NJ, Watkins WM. Reduction of the efficacy of antifolate antimalarial therapy by folic acid supplementation. Am J Trop Med Hyg 2005;73:166-70
48. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK, Kabole FM. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial. Lancet 2006;367:133-43.
49. Tielsch JM, Khatry SK, Stoltzfus RJ, Katz J, LeClerq SC, Adhikari R, Mullany LC, Shresta S, Black RE. Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: Community-based, cluster-randomised, placebo-controlled trial. Lancet 2006;367:144-52.
50. Abdulla S, Schellenberg JA, Nathan R, Mukasa O, Marchant T, Smith T, Tanner M, Lengeler C. Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: Comunity cross sectional study. BMJ 2001;322:270-3.
51. Menendez C, Kahigwa E, Hirt R, Vounatsou. P, Aponte JJ, Font F, Acosta CJ, Schellenberg DM, Galindo CM. Kimario J, Urassa H, Brabin B, Smith TA, Kitua AY, tanner M, Alonso PL. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 1997;350:844-50.
52. Brabin BJ, Premji Z, Verhoeff F. An analysis of anemia and child mortality. J Nutr 2001;131(2S-2):636S-45S.
53. Clark IA, Chaudhri G. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol 1988;70:99-103.
54. Kurtzhals JA, Rodrigues O, Addae M, Commey JO, Nkrumah FK, Hviid L. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol 1997;97:169-74.
55. Greenwood BM. The epidemiology of malaria. Ann Trop Med Parasitol 1997;91:763-9.
56. Snow RW, Marsh K. The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol 2002;52:235-64.
57. Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, ter Kuile F, Chongsuphajaisiddhi T, White NJ. Factors contributing to anemia after uncomplicated falciparurn malaria. Am J Trop Med Hyg 2001; 65:614-22.
58. Shankar AH. Nutritional modulation of malaria morbidity and mortality. J Infect Dis 2000; 182(suppl 1):S37-53.
59. Osifo BL, Chikamba CY, Seriki R, Aderele WI. Folate levels in protein malnourished Nigerian children. Trop Geogr Med 1974;26:379-83.
60. Akinsete FI, Boyo AE. Studies on folic acid in Nigerian infants and pre-school children. J Trop Pediatr Environ Child Health 1977;23:202-5.
61. Fleming AF, Werblinska B. Anaemia in childhood in the guinea savanna of Nigeria. Ann Trop Paediatr 1982; 2:161-73.
62. Akenzua GI, Ihongbe JC, Imasuen IW, Haemopoietic response of Nigerian village children to iron, folate supplementation and malaria prophylaxis. J Trop Pediatr 1985;31:59-62.
63. Menendez C, Fleming AF, Alonso PL. Malaria-related anaemia. Parasitol Today 2000;16:469-76.
64. English M, Snow RW. Iron and folic acid supplementation and malaria risk. Lancet 2006;367:90-1.
65. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983;61:1005-16.
66. Isah HS, Fleming AF, Ujah IA, Ekwempu CC. Anaemia and iron status of pregnant and non-pregnant women in the guinea savanna of Nigeria. Ann Trop Med Parasitol 1985;79:485-93.
67. Fleming AF, Ghatoura GB, Harrison KA, Briggs ND, Dunn DT. The prevention of anaemia in pregnancy in primigravidae in the guinea savanna of Nigeria. Ann Trop Med Parasitol 1986;80:211-33.
68. Matteelli A, Donato F, Shein A, Muchi JA, Leopardi O, Astori L, Carosi G. Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. Ann Trop Med Parasitol 1994;88:475-83.
69. Gail K, Herms V. Influence of pteroylglutamic acid (folic acid) on parasite density (Plasmodium falciparum) in pregnant women in West Africa. Z Tropenmed Parasitol 1969;20:440-50. (in German)
70. Mbaye A, Richardson K, Balajo B, Dunyo S, Shulman C, Milligan P, Greenwood B, Walraven G. Lack of inhibition of the antimalarial action of sulfadoxine-pyrimethamine when used for intermittent preventive treatment in Gambian primigravidae. Am J Trop Med Hyg 2006;74:960-4.
71. Nacher M, McGready R, Stepniewska K, Cho T, Looareesuwan S, White NJ, Nosten F. Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy. Trans R Soc Trop Med Hyg 2003;97:273-6.
72. Mahomed K. Folate supplementation in pregnancy. Cochrane Database Syst Rev 2000;(2):CDO00183. (subsequently withdrawn)
73. Baumslag N, Edelstein T, Metz J. Reduction of incidence of prematurity by folic acid supplementation in pregnancy. Br Med J 1970;1:16-7.
74. Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, Hkirijaroen L, Looareesuwan S, White NJ. Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999;354:546-9.
75. Guyatt HL, Snow RW, The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 2001;64(1-2 suppl):36-44.
76. Duffy PE, Fried M. Malaria in the pregnant woman. Curr Top Microbiol Immunol 2005;295:169-200.
77. van den Broek NR, Letsky EA. Etiology of anemia in pregnancy in south Malawi. Am J Clin Nutr 2000;72(1 suppl):247S-56S.